Operating Segments and Related Information (Tables)

12 Months Ended

Dec. 31, 2012

Operating Segments and Related Information [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following table presents certain operating division information in accordance with the provisions of ASC 280, Segment Reporting.

(in thousands)	Spire Solar			Spire Biomedical		Corporate		Total Company
December 31, 2012
Net sales and revenues	$	15,255		$	6,855	$	—	$	22,110
Operating income (loss) from continuing operations	(7,280		)	677		—		(6,603		)
Total assets	7,757			1,499		6,651		15,907
Capital expenditures	83			8		52		143
Depreciation and amortization	369			208		227		804
Share-based compensation	61			43		98		202
	Spire Solar			Spire Biomedical		Corporate		Total Company
December 31, 2011
Net sales and revenues	$	50,957		$	7,785	$	—	$	58,742
Operating income (loss) from continuing operations	(2,346		)	1,503		—		(843		)
Total assets	11,229			1,787		8,475		21,491
Capital expenditures	90			—		107		197
Depreciation and amortization	355			356		328		1,039
Share-based compensation	129			45		171		345

Revenues By Geography [Table Text Block]

The following table shows net sales and revenues by geographic area (based on customer location) for the years ended December 31:

(in thousands)	2012		%		2011		%
United States	$	10,436	47	%	$	29,827	51	%
Asia	7,971		36	%	21,666		37	%
Europe / Africa	3,628		17	%	5,258		9	%
Rest of the world	75		—	%	1,991		3	%
	$	22,110	100	%	$	58,742	100	%